4,0
23 dec 2022
Anonieme werknemer
Huidige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Company with a bright future and a strong pipeline of potentially innovative medicines. Gaining a strong foothold in the US market. Well funded and able to invest in the "next big thing".
Minpunten
Inexperienced senior management not suited for taking the company to the next level although they are bringing in more seasoned management. Work Life Balance not great although it is improving through localizing much of the work and adding more resources.